First News

  [96 Pages Report] The   OTC tests market   is projected to reach USD 22.2 billion by 2024 from USD 11.9 billion in 2018, at CAGR of 11.0% during the forecast period. The growth of the OTC tests market is mainly driven by the rising prevalence of target diseases and disorders, such as diabetes and infectious diseases, both prominent ailments across the globe that require rapid and effective testing. Download a PDF Brochure @   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78819178 By product type, infectious disease tests are expected to be the fastest-growing segment in the OTC Test market during the forecast period. The infectious disease tests segment is projected to grow at the highest CAGR between 2018 and 2024. Growth in this market can be attributed to factors such as the increasing number of HIV-infected individuals across the globe, coupled with increasing availability and awareness about HIV OTC testing in emerging markets such as India, Brazil, ...

Rising prevalence of target diseases and disorders, such as diabetes and infectious diseases, both prominent ailments across the globe that require rapid and effective testing. MarketsandMarkets forecasts the  Over The Counter/OTC Test Market  is projected to reach  USD 22.2 billion by 2024 from USD 11.9 billion in 2018 , at  CAGR of 11.0%  during the forecast period. Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78819178 Infectious disease tests are expected to be the fastest-growing segment in the OTC Test market during the forecast period. The infectious disease tests segment is projected to grow at the highest CAGR between 2018 and 2024. Growth in this market can be attributed to factors such as the increasing number of HIV-infected individuals across the globe, coupled with increasing availability and awareness about HIV OTC testing in emerging markets such as India, Brazil, and China. Lateral flow assays segment is g...

The OTC tests market is projected to reach USD 22.2 billion by 2024 from USD 11.9 billion in 2018, at CAGR of 11.0% during the forecast period. The growth of the OTC tests market is mainly driven by the rising prevalence of target diseases and disorders, such as diabetes and infectious diseases, both prominent ailments across the globe that require rapid and effective testing. Introduction of combined kits for testing pregnancy and ovulation is expected to provide new growth opportunities for players in the OTC test market. The major players operating in the OTC tests market are OraSure Technologies (US), Roche Diagnostics (Switzerland), and i-Health Lab (US), AccuBioTech (China), NOWDiagnostics Company (US), Abbott Laboratories (US), Sinocare (China), LabStyle Innovations (US), SD Biosensor (South Korea), ACON Laboratories (US), bioLytical Laboratories (Canada). A majority of the leading players in the market focus on both organic and inorganic growth strategies such as collaborations...